Bristol-Myers Squibb Co. (BMY)
$25.65
0.49 (+1.95%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $25.16 |
| Daily Range | $25.11 - $25.75 |
| 52-Week Range | $17.23 - $25.10 |
| Market Cap | $50.81B |
| P/E Ratio | 13.12 |
| Dividend (Yield) | 1.24 (4.90%) |
| Volume | 32,040,508 |
| Average Daily Volume | 14,046,000 |
BMY
VS S&P 500 (SPY)
How do you think BMY will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BMY Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BMY News and Commentary
- T.V ads for drugs don't work,study finds – Blog at The Motley Fool
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- 7 Dividend Divas – The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- UPDATE 1-FDA OKs Abilify for child autism irritability – Reuters
- Your Heart or Your Stomach? – The Motley Fool
- Up 80%, It's Time to Sell – The Motley Fool
- UPDATE: FDA Warns Doctors On Using Plavix With Heartburn Meds – SmartMoney
- FDA:Doctors Should Avoid Using Heartburn Medicines With Plavix – SmartMoney
- A Big Upgrade for Sanofi-Aventis – The Motley Fool
- 4-Star Stocks Poised to Pop: Alkermes – The Motley Fool
- Music to Health-Care Investors' Ears – The Motley Fool
- Abbott Puts a Nail in Merck's Coffin – The Motley Fool
- Aspirin without Plavix as good after heart bypass – Reuters
- UPDATE 1-Bristol-Myers shares rise on plan to divest Mead – Reuters
- Bristol-Myers Squibb Announces Split-Off Of Mead Johnson – SmartMoney
- RPT-UPDATE 1-Bristol-Myers to spin off Mead stock – Reuters
- Medicines Co. blood thinner still has hope: doctors – Reuters
- Proposed AstraZeneca Anticlotting Drug Better Than Plavix:Study – SmartMoney
RSS Headlines
Fool UK
